Named on one round in the feed.
Since 2017-03-13
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
HistoSonics HistoSonics® is developing a non-invasive, robotically assisted platform capable of destroying tissue at a sub-cellular level. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $8.3M | 2017-03-13 | [ PART ] |
No sector on record.